Quince Therapeutics share price logo

Quince Therapeutics

NASDAQ: QNCX

$31.73

+2.37

(+8.07%)

as on

Bell Icon

This instrument is not available for trading on the INDmoney app on 9 Oct 2026

Quince Therapeutics Stock Performance

as on October 10, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $29.84
    $37.00
    downward going graph

    5.96%

    Downside

    16.61%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $15.10
    $909.98
    downward going graph

    52.41%

    Downside

    2767.89%

    Upside

    downward going graph

Quince Therapeutics share price movements today

Previous Close
$29.36
Open
$30.35
Volume
304.6K
Market Cap
$30.9M
Day's Low - High
$29.84 - $37.00
52 Week Low - High
$15.10 - $909.98

Quince Therapeutics Historical Returns

1 Month Return
+ 9.56 %
3 Month Return
+ 80.9 %
1 Year Return
-91.52 %
3 Year Return
-85.71 %
5 Year Return
0 %

Quince Therapeutics Stock Fundamentals & Key Indicators

Check Quince Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$30.9M

EPS (TTM)

-68.91

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.43

Industry PE ratio

-3.02

PEG Ratio

-0.02

EBITDA

-72.3M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-413.28%

Quince Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Quince Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$30.9MNA-0.430.00%0.00%
Neutral$78.6B-26.21%-24.69-12.57%0.00%
StrongBuy$127.6B185.06%29.0686.04%0.00%
Buy$76.4B35.73%17.6684.86%0.50%

Stock Returns calculator for Quince Therapeutics Stock including INR - Dollar returns

The Quince Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Quince Therapeutics investment value today

Current value as on today

₹9,251

Returns

-₹90,749

(-90.75%)

Returns from Quince Therapeutics Stock

-₹91,516 (-91.52%)

Dollar Impact

₹767 (+0.77%)

Analyst Recommendation on Quince Therapeutics Stock

Based on 5 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 5 analysts, 100% of analysts recommend a 'BUY' rating for Quince Therapeutics. Average target price of $75.43

Quince Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Quince Therapeutics.

What analysts predicted

57.93%UPSIDE

Target Price

$75.43

Current Price

$31.73

Analyzed by

5 Analysts

High

$98

Target

$75.43

Low

$68

Quince Therapeutics target price $75.43, a slight upside of 57.93% compared to current price of $31.73. According to 5 analysts rating.

Indian Investors' Interest in Quince Therapeutics Stock

Search interest for Quince Therapeutics Stock has decreased by -39% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-39% versus previous 30 day period

Quince Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
0
-
0
-
-
0
-
Operating Income
-11
-28
-5
-10
-14
-9
-13
-19
-11
-79
EBITDA
-8
-8
-8
-12
-12
-15
-11
-16
30
-75
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-11
-27
-5
-12
-14
-15
-13
-36
30
-75
Income Tax Expense
0
0
0
0
0
0
0
3
-5
0
Net Income
-11
-27
-5
-12
-15
-16
-13
-39
35
-75
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Quince Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Mar 2024
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
-
-
-
-
-
-
0
Operating Income
-10
-12
-39
-78
-90
-52
-34
-57
-50
EBITDA
-10
-12
-38
-78
-89
-50
-26
-35
-80
Interest Expense
1
0
-
-
-
0
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-12
-12
-36
-76
-89
-51
-31
-56
-80
Income Tax Expense
-
-
-
-
-
0
0
0
3
Net Income
-12
-12
-36
-76
-89
-51
-31
-56
-83
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Quince Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-11
-27
-5
-12
-15
-16
-13
-39
35
-75
Operating Cash Flow
-8
-8
-7
-7
-9
-11
-9
-10
-7
-18
Investing Cash Flow
8
-4
7
10
10
6
-1
8
12
8
Financing Cash Flow
0
0
-5
-
0
14
1
2
9
108
Change in Cash
1
-13
-5
3
1
9
-10
0
12
97

Quince Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Mar 2024
Dec 2024
Dec 2025
Net Income
-12
-12
-36
-76
-89
-51
-31
-56
-83
Operating Cash Flow
-9
-11
-33
-50
-62
-44
-18
-31
-41
Investing Cash Flow
0
-46
-17
-52
58
18
-5
21
23
Financing Cash Flow
7
75
77
118
6
0
0
-4
17
Change in Cash
-2
17
26
15
2
-25
-23
-14
0

Global Institutional Holdings in Quince Therapeutics

Check out the Institutions with significant holdings in Quince Therapeutics.

Funds
Holdings
Vanguard
0.91%
Victory Portfolios III
0.36%

Insights on Quince Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, QNCX stock has moved up by 8.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 115.5% return, outperforming this stock by 201.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 738.6% return, outperforming this stock by 830.1%

About Quince Therapeutics

Quince Therapeutics, Inc. (QNCX) operates as a biopharmaceutical firm dedicated to developing targeted treatments for debilitating and rare diseases. A cornerstone of their innovation is an extensive bone-targeting drug delivery platform, engineered to accurately transport diverse therapeutic agents, such as small molecules, peptides, and large molecules, directly to affected bone areas like fractures and disease sites. Leading their pipeline is NOV004, an anabolic peptide meticulously designed to pinpoint and accumulate its therapeutic action precisely at bone fracture locations. The company, previously known as Cortexyme, Inc., officially rebranded as Quince Therapeutics, Inc. in August 2022. Established in 2012, Quince Therapeutics is headquartered in South San Francisco, California.
OrganisationQuince Therapeutics
Headquarters601 Gateway Blvd, South San Francisco, CA, 94080, US
IndustryBiotechnology
CEODirk Thye

Key Management of Quince Therapeutics

Name

Title

Dr. Guenter R. Janhofer M.D., Ph.D.

Chief Scientific Officer

FAQs

What is Quince Therapeutics share price today?

Quince Therapeutics share price today is $31.73 as on at the close of the market. Quince Therapeutics share today touched a day high of $37.00 and a low of $29.84.

What is the 52 week high and 52 week low for Quince Therapeutics share?

Quince Therapeutics share touched a 52 week high of $909.98 on and a 52 week low of $15.10 on . Quince Therapeutics stock price today i.e. is closed at $31.73,which is 96.51% down from its 52 week high and 110.13% up from its 52 week low.

What is Quince Therapeutics's market capitalisation today?

Quince Therapeutics market capitalisation is $0.00T as on .

How to invest in Quince Therapeutics Stock (QNCX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Quince Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Quince Therapeutics Stock (QNCX) from India?

Indian investors can start investing in Quince Therapeutics (QNCX) shares with as little as ₹96.779998779297 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹967.80 in Quince Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Quince Therapeutics share’s latest price of $31.73 as on October 10, 2026 at 8:45 am IST, you will get 0.3152 shares of Quince Therapeutics. Learn more about fractional shares .